DOI: 10.36347/sasjs.2023.v09i09.013

Pages: 797-803

Introduction: Tru-cut biopsy is now one of the useful means of obtaining early and accurate histopathological diagnosis. It is easy and can be performed on an outpatient basis. It also avoids unnecessary excisional biopsy. Objective: To correlate findings of trucut biopsy in Diagnosis of Palpable Breast Lesions. Material and Methods: A cross sectional, observational study of one years conducted in Dept. Of Surgery, Shaheed Suhrawardy Medical College & Hospital, Dhaka, Bangladesh from January to December 2017. The study includes 100 patients of palpable breast lump. Trucut biopsy was performed using a Tru-Cut gun BARD MAX-CORE with an 18-gauge needle by means of 4 successive insertions with different angulations of the needle into the lesion’s core. Results: The study includes 100 patients, Trucut Biopsy findings correlated with the histopathological findings in 97 of 100 cases (97.2%), which included 27 of 28 (96.4%) of the benign lesions and 71 of 72 (98.6%) of the malignant lesions. Conclusion: The results of this study suggest that TCB is an accurate, reliable and a safe method of establishing the diagnosis of cancer in patients with breast lesions. Our results yielded a high sensitivity of 95.65% with 96.88% specificity when compared with FNAC in the diagnosis of breast cancer especially when radiology is not diagnostic. Thus, trucut biopsy should replace fine needle aspiration in the preoperative assessment of suspicious breast lumps.